Issue 1/2021
Annual Review Issue: Challenges in lung and thoracic pathology
Content (13 Articles)
Morphologic and molecular classification of lung neuroendocrine neoplasms
Jasna Metovic, Marco Barella, Fabrizio Bianchi, Paul Hofman, Veronique Hofman, Myriam Remmelink, Izidor Kern, Lina Carvalho, Linda Pattini, Angelica Sonzogni, Giulia Veronesi, Sergio Harari, Fabien Forest, Mauro Papotti, Giuseppe Pelosi
Update on genetically defined lung neoplasms: NUT carcinoma and thoracic SMARCA4-deficient undifferentiated tumors
Kyriakos Chatzopoulos, Jennifer M. Boland
Predictive biomarkers for response to immune checkpoint inhibitors in lung cancer: PD-L1 and beyond
Hironori Uruga, Mari Mino-Kenudson
Cytology samples and molecular biomarker testing in lung cancer—advantages and challenges
Sule Canberk, Marianne Engels
Pleural mesothelioma classification update
Mary Beth Beasley, Francoise Galateau-Salle, Sanja Dacic
Challenges in lung and thoracic pathology: molecular advances in the classification of pleural mesotheliomas
Lynnette Fernandez-Cuesta, Lise Mangiante, Nicolas Alcala, Matthieu Foll
Vaping-related lung injury
Maxwell L. Smith, Michael B. Gotway, Laura E. Crotty Alexander, Lida P. Hariri
Molecular approach to the classification of chronic fibrosing lung disease—there and back again
Stijn E. Verleden, Peter Braubach, Mark Kuehnel, Nicolas Dickgreber, Emily Brouwer, Pauline Tittmann, Florian Laenger, Danny Jonigk
Molecular pathology of thymomas: implications for diagnosis and therapy
Alexander Marx, Djeda Belharazem, De-Hyung Lee, Zoran V. Popovic, Christoph Reißfelder, Berthold Schalke, Sebastian Schölch, Philipp Ströbel, Cleo-Aron Weis, Yosuke Yamada
Common and rare carcinomas of the thymus
Anja C. Roden, Malgorzata Szolkowska
Recent advances and conceptual changes in the classification of neuroendocrine tumors of the thymus
Hanibal Bohnenberger, Philipp Ströbel
The pulmonary pathology of COVID-19
Hans Bösmüller, Matthias Matter, Falko Fend, Alexandar Tzankov